Sommermeyer Daniel, Neudorfer Julia, Weinhold Monika, Leisegang Matthias, Engels Boris, Noessner Elfriede, Heemskerk Mirjam H M, Charo Jehad, Schendel Dolores J, Blankenstein Thomas, Bernhard Helga, Uckert Wolfgang
Max-Delbrück-Center for Molecular Medicine, Berlin, Germany.
Eur J Immunol. 2006 Nov;36(11):3052-9. doi: 10.1002/eji.200636539.
T cell receptor (TCR) gene transfer is a convenient method to produce antigen-specific T cells for adoptive therapy. However, the expression of two TCR in T cells could impair their function or cause unwanted effects by mixed TCR heterodimers. With five different TCR and four different T cells, either mouse or human, we show that some TCR are strong--in terms of cell surface expression--and replace weak TCR on the cell surface, resulting in exchange of antigen specificity. Two strong TCR are co-expressed. A mouse TCR replaces human TCR on human T cells. Even though it is still poorly understood why some TCRalpha/beta combinations are preferentially expressed on T cells, our data suggest that, in the future, designer T cells with exclusive tumor reactivity can be generated by T cell engineering.
T细胞受体(TCR)基因转移是一种为过继性治疗生产抗原特异性T细胞的便捷方法。然而,T细胞中两种TCR的表达可能会损害其功能,或因混合的TCR异二聚体而产生不良影响。我们使用五种不同的TCR和四种不同的T细胞(小鼠或人类来源),发现就细胞表面表达而言,一些TCR很强,会取代细胞表面较弱的TCR,从而导致抗原特异性的交换。两种强TCR可共表达。一种小鼠TCR可取代人类T细胞上的人类TCR。尽管目前仍不清楚为何某些TCRα/β组合会优先在T细胞上表达,但我们的数据表明,未来可通过T细胞工程生成具有独特肿瘤反应性的定制T细胞。